Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2026-02-10 @ 12:15 AM
Study NCT ID:
NCT02546661
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-07
First Post:
2015-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-09
Completion Date Type:
ESTIMATED
First Submit Date:
2015-08-27
First Submit QC Date:
None
Study First Post Date:
2015-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-06
Last Update Post Date:
2025-11-07
Last Update Post Date Type:
ESTIMATED